Vol. 44 (4): 750-757, July – August, 2018

doi: 10.1590/S1677-5538.IBJU.2017.0516


Sarah Prattley 1, James Voss 1, Stephanie Cheung 1, Robert Geraghty 1, Patrick Jones 1, Bhaskar K. Somani 1
 1 University Hospital Southampton, NHS Trust, United Kingdom, UK


Objective: To assess outcomes of ureteroscopy for treatment of stone disease in the elderly. Ureteroscopy (URS) is an increasingly popular treatment modality for urolithiasis and its applications are ever expanding with the development of newer technologies. Its feasibi­lity and outcomes within the elderly population to our knowledge remain under-reported.

Materials and Methods: We examined the patient demographics and surgical outcomes from our prospective database for patients ≥70 years who underwent URS for urolithiasis, in a 5-year period between March 2012 and December 2016.

Results: A total of 110 consecutive patients underwent 121 procedures (1.1 procedure/ patient) with a mean age of 77.2 years (range: 70-91 years). Stone location was in the kid­ney/ pelviureteric junction (PUJ) in 29%, ureter in 37% and in multiple locations in 34%. The initial and final stone free rate (SFR) was 88% and 97% respectively. While 73% were done as true day case procedures, 89% patients were discharged within 24 hours. Eleven patients (9%) underwent complications of which 10 were Clavien I/II including acute urinary retention, urinary tract infection, stent symptoms and pneumonia. One patient underwent Clavien IV complication where they needed intensive care unit admission for urosepsis but fully recovered and were discharged home subsequently.

Conclusion: Ureteroscopy is a safe and effective method of managing urolithiasis in elder­ly patients. Although most patients are discharged within 24-hours, consideration needs to be made for patients where social circumstances can impact their discharge planning.

Keywords: Ureteroscopy; Calculi; Therapeutics

[Full text]